ANGIODYNAMICS, INC.

(ANGO)
  Report
Real-time Estimate Cboe BZX  -  05/26 09:54:52 am EDT
19.10 USD   -0.37%
05/23AngioDynamics Seeks M&A
CI
05/23TRANSCRIPT : AngioDynamics, Inc. Presents at UBS Global Healthcare Conference, May-23-2022 04:15 PM
CI
05/16AngioDynamics to Present at the UBS Global Healthcare Conference
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Buy: AngioDynamics

01/12/2022 | 05:03pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ANGIODYNAMICS, INC. -0.50% 19.075 Delayed Quote.-30.49%
ON SEMICONDUCTOR CORPORATION 1.60% 57.085 Delayed Quote.-17.20%
All news about ANGIODYNAMICS, INC.
05/23AngioDynamics Seeks M&A
CI
05/23TRANSCRIPT : AngioDynamics, Inc. Presents at UBS Global Healthcare Conference, May-23-2022..
CI
05/16AngioDynamics to Present at the UBS Global Healthcare Conference
BU
05/10TRANSCRIPT : AngioDynamics, Inc. Presents at Bank of America 2022 Healthcare Conference, M..
CI
05/03AngioDynamics to Present at the BofA Securities Healthcare Conference
BU
04/27ANGIODYNAMICS : Launches APEX-AV Study in Partnership with PERT Consortium
PU
04/14ANGIODYNAMICS : New Clinical Study to Assess Auryon Atherectomy Treatment in Below-the-Kne..
PU
04/14ANGIODYNAMICS : First Patients Treated in PRESERVE Clinical Study
PU
04/08AngioDynamic Fiscal Q3 Sales Trail Estimates Amid COVID-19, Supply Chain Headwinds, Opp..
MT
04/07ANGIODYNAMICS INC Management's Discussion and Analysis of Financial Condition and Resu..
AQ
More news
Analyst Recommendations on ANGIODYNAMICS, INC.
More recommendations
Financials (USD)
Sales 2022 312 M - -
Net income 2022 -24,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -30,3x
Yield 2022 -
Capitalization 743 M 743 M -
Capi. / Sales 2022 2,38x
Capi. / Sales 2023 2,20x
Nbr of Employees 800
Free-Float 94,5%
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 19,17 $
Average target price 36,00 $
Spread / Average Target 87,8%
EPS Revisions
Managers and Directors
James Christopher Clemmer President, Chief Executive Officer & Director
Stephen A. Trowbridge Chief Financial Officer & Executive Vice President
Howard W. Donnelly Independent Non-Executive Chairman
David D. Helsel SVP-Global Operations, Research & Development
Kim L. Seabury Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ANGIODYNAMICS, INC.-30.49%743
ABBOTT LABORATORIES-19.58%198 189
MEDTRONIC PLC2.02%141 586
BECTON, DICKINSON AND COMPANY2.60%71 882
HOYA CORPORATION-19.84%39 348
BAXTER INTERNATIONAL INC.-12.41%37 860